ETFs Bausch + Lomb Corporation

Equities

BLCO

CA0717051076

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 01:00:02 2024-07-03 pm EDT 5-day change 1st Jan Change
14.66 USD 0.00% Intraday chart for Bausch + Lomb Corporation -0.74% -14.07%

ETFs positioned on Bausch + Lomb Corporation

Name Weight AuM 1st Jan change Investor Rating
0.40% 12 M€ -.--% -
Bausch + Lomb Corporation is an eye health company. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment includes both a contact lens and a consumer eye care business that consists of contact lens care products, over-the-counter eye drops and eye vitamins. The Pharmaceuticals segment consists of generic pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. The Surgical segment consists of medical device equipment, consumables, instruments and technologies for the treatment of cataracts, corneal and vitreous and retinal eye conditions, which includes delivery systems, phacoemulsification equipment and other surgical instruments and devices for cataract surgery. Its brands consist of PreserVision, Biotrue, Artelac, Alaway, Mioclear, Ocuvite, XIIDRA, Vyzulta, Lotemax, Prolensa, Minims, INFUSE, and many more.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
14.66 USD
Average target price
18.75 USD
Spread / Average Target
+27.90%
Consensus
  1. Stock Market
  2. Equities
  3. BLCO Stock
  4. ETFs Bausch + Lomb Corporation